Approval · Notice of Compliance 10101 · 2009
SECTRAL: Notice of Compliance 10101
Issued March 18, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10101
- Date
- March 18, 2009
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing and formulation
- Therapeutic class
- Antianginal / antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SECTRAL | Not yet assigned | — |
Medicinal ingredients
- ACEBUTOLOL HCL 100 MG per TAB
- ACEBUTOLOL HCL 200 MG per TAB
- ACEBUTOLOL HCL 400 MG per TAB